| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/06/2008 | US7368109 For ameliorating acquired immunodeficiency syndrome (AIDS), an antoimmune disease, or graft rejection |
| 05/06/2008 | US7368108 Glycopeptide remodeling using amidases |
| 05/06/2008 | CA2607709A1 Method for producing anti-idiotypic antibodies |
| 05/06/2008 | CA1341572C Protective antibodies to serotypic determinants of flagellar antigens |
| 05/02/2008 | WO2008050907A1 Antibody against rgd in amino acid sequence of extracellular matrix protein and production method and use of the same |
| 05/02/2008 | WO2008050825A1 Method of producing basement membrane collagen |
| 05/02/2008 | WO2007135194A9 Preparation and uses of gene sequences encoding chimerical glycosyltransferases with optimized glycosylation activity |
| 05/02/2008 | WO2007082173A3 Compositions and methods for enhancing the identification of prion protein prpsc |
| 05/02/2008 | WO2007061631A8 Production of glycoproteins with reduced o-glycosylation |
| 05/02/2008 | WO2007028573A9 Tumor-associated peptides binding to human leukocyte antigen (hla) class i or ii molecules and related anti-cancer vaccine |
| 05/02/2008 | CA2667263A1 Antibody against rgd in amino acid sequence of extracellular matrix protein and production method and use of the same |
| 05/01/2008 | US20080104721 Nucleic acids isolated from crustaceans; linked to expression regulatory elements; analyzing cells by detection of signal; kits |
| 05/01/2008 | US20080103113 Reduced level of background gene expression; responds to submicromolar concentrations of nonsteroidal ligand |
| 05/01/2008 | US20080103098 Recombinant Expression of Proteins in a Disulfide-Bridged, Two-Chain Form |
| 05/01/2008 | US20080103090 Polynucleotide; hybridization; recombinant vectors, host cells; diagnosis, prognosis; anticarcinogenic and antiproliferative agents; drug screening; genetic engineering |
| 05/01/2008 | US20080102510 Transgenic cells for use as bioreactors in expression of amidated peptides |
| 05/01/2008 | US20080102509 Transgenic cells for use as bioreactors in expression of amidated peptides |
| 05/01/2008 | US20080102492 Methods and compositions for the prevention and treatment of anemia |
| 05/01/2008 | US20080102491 Bacterial host cell for the direct expression of peptides |
| 05/01/2008 | US20080102490 Interferon-like protein zcyto21 |
| 05/01/2008 | US20080102489 Dna molecules encoding ligand gated ion channels from dermacentor variabilis |
| 05/01/2008 | US20080102488 Microorganism of Enterobacteriacae Genus Haboring Genes Associated With L-Carnitine Biosynthesis and Method of Producing L-Carnitine Using the Microorganism |
| 05/01/2008 | US20080102458 Polymorphic loci that differentiate escherichia coli 0157:H7 from other strains |
| 05/01/2008 | US20080102323 an amino acid capable of binding to the metallic complex by a coordinate bond arranged at an active site within the redox enzyme or at a controlled position near the active site; when a mediator is introduced into the enzyme, a mediator-introduced position is controlled to be held at or near active site |
| 05/01/2008 | US20080102115 Modified coagulation factor IX polypeptides and use thereof for treatment |
| 05/01/2008 | US20080102088 against tularemia; subcellular protein expressed from Francisella tularensis infected mammal subculture growing in synthetic salts medium of weak acidity |
| 05/01/2008 | US20080102083 Compositions and Methods for the Preparation of Human Growth Hormone Glycosylation Mutants |
| 05/01/2008 | US20080102079 Poultry Vaccine, for Necrotic Enteritis, Comprising a Mutated Clostridium Perfringens Alpha Toxin Antigen, and Methods of Producing the Vaccine |
| 05/01/2008 | US20080102077 Nucleic and Protein Sequences from the Hxhv Virus and Uses Thereof |
| 05/01/2008 | US20080102075 Enzymatic polypeptide which cleaves tumor necrosis factor receptor for use in treatment and prevention of arthritis and inflammatory disorders |
| 05/01/2008 | US20080102072 Cytokine specific immunoglobulin for prevention and treatment of diabetes, autoimmune and inflammatory disorders |
| 05/01/2008 | US20080102071 T cell inhibitory receptor compositions and uses thereof |
| 05/01/2008 | US20080102060 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
| 05/01/2008 | US20080102040 Inhibition of factor b, the alternative complement pathway and methods related thereto |
| 04/30/2008 | EP1916303A1 Nucleic acids encoding rearranged human immunoglobulin sequences from transgenic transchromosomal mice |
| 04/30/2008 | EP1916299A1 Dna, vector, transformant and method for producing apa protein |
| 04/30/2008 | EP1916298A1 Method for production of antibody |
| 04/30/2008 | EP1916256A2 Search for cancer markers by a novel screening method |
| 04/30/2008 | EP1915456A1 Cancerous disease modifying antibodies |
| 04/30/2008 | EP1915455A1 Cancerous disease modifying antibodies |
| 04/30/2008 | EP1819825A4 Thermostable omega-transaminases |
| 04/30/2008 | EP1458240B1 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
| 04/30/2008 | EP1446004B1 Exogenous protein expression system in an avian system |
| 04/30/2008 | EP1399023B1 COMPOSITIONS FOR SYSTEMIC ADMINISTRATION OF SEQUENCES ENCODING BONE MORPHOGENETIC PROTEINS& x9; |
| 04/30/2008 | EP1257176B1 Use of acid-stable proteases in animal feed |
| 04/30/2008 | EP1213297B1 Tachykinin peptides, precursor peptides thereof and genes encoding the same |
| 04/30/2008 | EP1212417B1 Promotion or inhibition of angiogenesis and cardiovascularization |
| 04/30/2008 | EP1183360B1 Modified cytokine for its stabilisation |
| 04/30/2008 | EP1173471B1 Pseudomycin analogs |
| 04/30/2008 | EP1058728B1 V-like domain binding molecules |
| 04/30/2008 | EP0983351B1 Nucleic acid binding proteins |
| 04/30/2008 | EP0983350B1 Nucleic acid binding proteins |
| 04/30/2008 | DE102006050332A1 DNS-Konstrukt und Verfahren zur fermentativen Herstellung von Fusionsproteinen DNA construct and methods for the fermentative production of fusion proteins |
| 04/30/2008 | CN101171334A Methods of producing proteins having triple-helix structure |
| 04/30/2008 | CN101168764A Method for producing anti-oxidation active peptide by glutelin powder biological enzyme method |
| 04/30/2008 | CN101168763A Method for preparing nano natural silk protein powder |
| 04/30/2008 | CN101168762A Method for preparing antihypertensive peptide from hairtail backbone by fermentation method |
| 04/30/2008 | CN100385012C Method for producing dipeptides |
| 04/30/2008 | CN100385011C Insertion of furin protease cleavage sites in membrane proteins and uses thereof |
| 04/30/2008 | CN100385010C Soybean oligopeptide production process |
| 04/30/2008 | CN100385006C Method for secretory production of glycoprotein having human-type sugar chain using plant cell |
| 04/30/2008 | CN100385005C Methods for the production of multimeric proteins, and related compositions |
| 04/30/2008 | CN100385004C Cold shock inducible expression and production of heterologous polypeptides |
| 04/30/2008 | CN100384998C Method for preparing recombinant goose interleukin-2 protein and its application |
| 04/30/2008 | CN100384880C Modified peptides as therapeutic agents |
| 04/30/2008 | CN100384879C Modified peptides as therapeutic agents |
| 04/30/2008 | CN100384878C Antibodies specific for human cd22 and their therapeutic anddiagnostic uses |
| 04/30/2008 | CN100384469C Treatment of pulmonary disease |
| 04/29/2008 | US7365184 B. anthracis prevention and treatment: mutant B. anthracis lacking luxS activity and furanone inhibition of growth, AI-2 quorum sensing, and toxin production |
| 04/29/2008 | US7365171 Chemotactic cytokine for use in diagnosis, prevention and treatment of tumors |
| 04/29/2008 | US7365168 Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis |
| 04/29/2008 | US7365167 Specified complementary determining region (CRD) amino acid sequences; specific binding activity for a cryptic collagen epitope; angiogenesis inhibition, antimetastasis, and tumor-targeted therapy uses |
| 04/29/2008 | US7365163 Isolation nulceic acid; genetic engineering; screening antagonist; aminobutyric acid receptor; diagnostics for detecting aberrant GABAA receptor epsilon subunit (GABRE) and ET2 expression, therapy of disorders involving ET2 and GABRE |
| 04/29/2008 | US7365162 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 04/29/2008 | US7365160 Membrane protein for use as diagnostic tool in detection and screening of xenobiotics; drug screening |
| 04/29/2008 | US7365157 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of immunological disorders |
| 04/29/2008 | US7365154 Use as an immunogen to generate anti-integrin antibodies; a mimotope; vaccinating against angiogenic and metastatic diseases |
| 04/29/2008 | US7365052 Tendon-inducing methods |
| 04/29/2008 | US7364893 infectious laryngotracheitis viral genome which contains a deletion in the glycoprotein gG gene, US2 gene, UL47-like gene. ORF4 gene; polypeptide is derived from infectious bronchitis virus, Newcastle disease virus, infectious bursal disease virus, and Marek's disease virus; vaccines |
| 04/29/2008 | US7364892 Enhanced protease for use in detergents, leather treatment and animal feeds |
| 04/29/2008 | US7364891 Mutated alkaline cellulase |
| 04/29/2008 | US7364890 Thermal tolerant avicelase from Acidothermus cellulolyticus |
| 04/29/2008 | US7364883 Process for producing poly-unsaturated fatty acids by oleaginous yeasts |
| 04/29/2008 | US7364882 Biocatalytically reducing of 7-cyano-7-dezazguanine in presence of nitrile oxidoreductase enzyme to 7-aminomethyl-7-dezazguanine |
| 04/29/2008 | US7364878 Improving gene expression in host cells vial use of vector comprising stabilizing anti-repressor (STAR) sequences; enhancer elements |
| 04/29/2008 | US7364877 Polynucleotides encoding disorazole polyketide synthase polypeptides |
| 04/29/2008 | US7364875 Method for producing medical and commercial grade poly-gamma-glutamic acid of high molecular weight |
| 04/29/2008 | US7364867 Nucleotide sequences which code a membrane protein for use in flavor intensification of in food, beverages or pharmaceuticals |
| 04/29/2008 | US7364864 ANGE gene in atopy |
| 04/29/2008 | US7364863 Monoclonal antibody for use in classification and identification of embryonic connective tissue progenitor cells; regenerative medicine |
| 04/29/2008 | US7364845 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cancer, psoriasis and nervous system disorders |
| 04/29/2008 | US7364842 Methods of identifying modulators of human retrovirus replication |
| 04/29/2008 | US7364743 Nucleotide sequence encoding PTD and CEA fusion protein, TAT-CEA fusion protein, anti-tumor vaccine and pharmaceutical composition for treating tumor comprising the fusion protein |
| 04/29/2008 | US7364739 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of Haemophilus influenzae infections |
| 04/29/2008 | US7364738 Monoclonal antibodies to the CLFA protein and method of use in treating infections |
| 04/29/2008 | US7364736 Immmunoglobulin which prevents binding of osteoprotegerin ligand (OPGL) to osteoclast differentiation and activation receptor (ODAR) for treatment and prevention of bone, inflammatory, arthritic and autoimmune disorders |
| 04/29/2008 | US7364733 antibodies that bind to Activated CD4+ T-cells (ACT-4) receptors; diagnostic or therapeutic use for immune disorders; selective suppression of immune response; allograft rejection, graft versus host disease, autoimmune diseases, allergies |
| 04/29/2008 | US7364731 Polypeptide variants |
| 04/29/2008 | US7364730 Human K+ channel and prognosing applications thereof |
| 04/29/2008 | US7364724 Recombinant super-compound interferon |